Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Boehringer launches iPhone app for patients on Gilotrif

App offers treatment guide for those taking its cancer drug

Boehringer Ingelheim Gilotrif iPhone appBoehringer Ingelheim has released an iPhone app for patients prescribed its cancer drug Gilotrif (afatinib).

The My Treatment Guide app offers tools such as a medication reminder alarm, diary and calendar to keep track of appointments - all fairly standard tools for this type of app.

More unusually though it also includes branded information about Gilotrif and on what to expect during treatment with the drug.

The app, which doesn't yet appear to be available in an Android version, also provides 'discussion topics' for a patient's visits to their doctor and links to patient support sites.

Launched in the US in 2013, Gilotrif was Boehringer's first cancer drug to reach the market following FDA approval for its use in non-small cell lung cancer (NSCLC) with common epidermal growth factor receptor (EGFR) mutations.

The personalised cancer drug was approved alongside a companion diagnostic developed by Qiagen to detect the presence of EGFR mutations.

Boehringer said at the time that it planned to support the Gilotrif's launch with a “comprehensive patient support programme” of services.

29th May 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics